Brennan J. Wadsworth

Author

Also Known As

B. J. Wadsworth, B.J. Wadsworth, Brennan J Wadsworth, Brennan J. Wadsworth, Brennan Wadsworth, Wadsworth, Brennan, Wadsworth, Brennan J.

Publications

501

Citations

H-Index

Concepts

All Affiliations

University of British Columbia BC Cancer Agency Karolinska Institutet Terry Fox Research Institute University of Cambridge

About

Brennan J. Wadsworth is an author at University of British Columbia specializing in cancer research, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	23
2	Pharmacology	1	1	23
3	Radiation Medicine	1	1	23
4	Radiation Therapy	1	1	23
5	Tumor Biology	1	1	23

Brennan J. Wadsworth

Publications

471

Citations

H-Index

Page 1

	Year	Citations
Maraviroc decreases CCL8-mediated migration of CCR5<sup>+</sup>regulatory T cells and reduces metastatic tumor growth in the lungs Elizabeth C. Halvorsen, Melisa J. Hamilton, Amelia G. Young, OncoImmunology	2016	101
ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice Emily B. Button, Guilaine K. Boyce, Anna Wilkinson, Alzheimer s Research & Therapy	2019	68
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development Etienne Melese, Elizabeth Franks, Rachel A. Cederberg, OncoImmunology	2021	60
Glutarate regulates T cell metabolism and anti-tumour immunity Eleanor Minogue, Pedro P. Cunha, Brennan J. Wadsworth, Nature Metabolism	2023	50
IL-33 increases ST2<sup>+</sup>Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner Elizabeth C. Halvorsen, S. Elizabeth Franks, Brennan J. Wadsworth, OncoImmunology	2018	47
Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy Pedro P. Cunha, Eleanor Minogue, Lena C.M. Krause, eLife	2023	44
Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype Val A. Fajardo, Éric Bombardier, Elliott M. McMillan, Disease Models & Mechanisms	2015	34
Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation Brennan J. Wadsworth, Rachel A. Cederberg, Che-Min Lee, Cancer Letters Tumor BiologyRadiation MedicineOncologyTumour ResponseRadiation Therapy	2020	23
Receptor-type protein tyrosine phosphatase alpha (PTPα) mediates MMP14 localization and facilitates triple-negative breast cancer cell invasion Lisa R. Decotret, Brennan J. Wadsworth, Ling Li, Molecular Biology of the Cell	2021	17
Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth Rachel A. Cederberg, S. Elizabeth Franks, Brennan J. Wadsworth, Frontiers in Oncology	2022	14

Page 1